In a landmark continuing collaboration, Answer ALS and Cedars-Sinai have announced the completed availability of the largest ...

Researchers from the University of California – San Diego (CA, USA) have worked backwards, identifying the pathway leading to ...

Kadimastem, the developer of the experimental amyotrophic lateral sclerosis (ALS) therapy AstroRx, is merging with NLS ...

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder that is marked by fasciculation, spasticity and progressive weakness of muscles, and results in difficulty speaking ...

Libra Therapeutics, Inc., ("Libra") a private biotech developing novel therapeutics to restore cellular balance and attenuate neurodegeneration, today announced the appointment of Shawn A. Scranton, ...

that surrounds neurons—such as multiple sclerosis. A study published in the Journal of Biological Chemistry found a plant-derived flavonoid—a type of chemical compound—called sulfuretin ...

Autophagy mediates the degradation of harmful material within lysosomes. In aggrephagy, the pathway mediating the degradation of aggregated, ubiquitinated proteins, this cargo material is collected in ...

Using a cutting-edge genomic technique, the team identified specific HERV expression signatures linked to multiple sclerosis and amyotrophic lateral sclerosis (also known as motor neurone disease).

Lady Sarra Hoy, the wife of Olympian Sir Chris Hoy, has revealed she has been diagnosed with Multiple Sclerosis (MS). The ambassador for neonatal charity Bliss broke the news as her husband said ...

During PINK1- and Parkin-mediated mitophagy, autophagy adaptors are recruited to damaged mitochondria to promote their selective degradation. Autophagy adaptors such as optineurin (OPTN) and NDP52 ...